Clinical trial
A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and…
NCT01731600 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT01731600 |
|---|---|
| Title | A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A |
| Official title | A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A |
| Acronym | pathfinder™5 |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Congenital Bleeding Disorder, Haemophilia A |
| Intervention type | Drug |
| Interventions | turoctocog alfa pegol |
| Enrollment | 68 |
| Start date | Feb 20, 2013 |
| Primary completion | Sep 15, 2014 |
| Completion | Sep 28, 2018 |
| First posted | Nov 22, 2012 |
| Last update posted | Nov 23, 2020 |
| Countries | Brazil, Canada, France, Greece, Israel, Italy, Japan, Lithuania, Malaysia, Portugal, Puerto Rico, Switzerland and 4 more |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: